# Pilot Study to Evaluate the Efficacy and Safety of Xvie Delivered Into the Scalp by Microneedling in Women With Self-perceived Thinning Hair

> **NCT07221773** · NA · ENROLLING_BY_INVITATION · sponsor: **Restore Biologics Holdings, Inc. dba Xtressé** · enrollment: 15 (estimated)

## Conditions studied

- Hair Thinning

## Interventions

- **OTHER:** XVIE

## Key facts

- **NCT ID:** NCT07221773
- **Lead sponsor:** Restore Biologics Holdings, Inc. dba Xtressé
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-29
- **Primary completion:** 2026-03
- **Final completion:** 2026-06
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07221773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07221773, "Pilot Study to Evaluate the Efficacy and Safety of Xvie Delivered Into the Scalp by Microneedling in Women With Self-perceived Thinning Hair". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT07221773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*